Michael Egan

Biography

 Dr. Egan joined Profectus Bioscience in 2008. Prior to that, Dr. Egan was with Wyeth Vaccines Research where he evaluated candidate HIV-1 vaccines in mice, guinea pigs, non-human primates and in phase I clinical trials. Dr. Egan received his Ph.D. in Immunology from the Johns Hopkins University School of Medicine and went on to do his postdoctoral training at Harvard Medical School. While at Harvard, Dr. Egan worked to evaluate the immunogenicity of several prototype plasmid DNA vaccines for HIV-1 in the rhesus macaque SHIV challenge model. Dr. Egan has served on numerous NIH scientific review committees and has numerous publications to his credit in the area of vaccine research and development. Dr. Egan brings to Profectus 15+ years of HIV and HIV vaccine research experience and significant experience with state-of-the-art immunological assays for monitoring cellular immune responses in animals and in clinical studies.  

Research Interest

 Prior to that, Dr. Egan was with Wyeth Vaccines Research where he evaluated candidate HIV-1 vaccines in mice, guinea pigs, non-human primates and in phase I clinical trials. Dr. Egan received his Ph.D. in Immunology from the Johns Hopkins University School of Medicine and went on to do his postdoctoral training at Harvard Medical School.